US Patent 10344765 | Patents | Expiry | Expiration | Dates

KAI PHARMS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

ETELCALCETIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10344765

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2034-06-27

Patent Use Code

Delist Requested

Application Number

208325

Patent Use Description

Product Number

2

KAI PHARMS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

ETELCALCETIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10344765

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2034-06-27

Patent Use Code

Delist Requested

Application Number

208325

Patent Use Description

Product Number

3

KAI PHARMS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

ETELCALCETIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10344765

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2034-06-27

Patent Use Code

Delist Requested

Application Number

208325

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10344765

U.S. Patents

KAI PHARMS INC

ETELCALCETIDE

10344765

Y

2034-06-27

208325

2

KAI PHARMS INC

ETELCALCETIDE

10344765

Y

2034-06-27

208325

3

KAI PHARMS INC

ETELCALCETIDE

10344765

Y

2034-06-27

208325

1